Neuronal vulnerability, pathogenesis, and Parkinson's disease.
about
A constraint-based modelling approach to metabolic dysfunction in Parkinson's diseaseNovel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's diseaseThe Synaptic Function of α-SynucleinInteractions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's diseaseHippocampal α-synuclein and interneurons in Parkinson's disease: Data from human and mouse models.Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?The rat striatum responds to nigro-striatal degeneration via the increased expression of proteins associated with growth and regeneration of neuronal circuitryEmbryonic development of selectively vulnerable neurons in Parkinson's disease.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase ActivityComparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons.Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditionsUnderstanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.Freezing of Gait in Parkinson's Disease Is Associated with Reduced 6-[(18)F]Fluoro-l-m-tyrosine Uptake in the Locus Coeruleus.Somatodendritic dopamine release: recent mechanistic insights.Targeting voltage-gated calcium channels in neurological and psychiatric diseases.Cellular models for Parkinson's disease.How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?Disentangling neural cell diversity using single-cell transcriptomics.Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.Selective neuronal vulnerability in Parkinson disease.Do Copy Number Changes in CACNA2D2, CACNA2D3, and CACNA1D Constitute a Predisposing Risk Factor for Alzheimer's Disease?Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.Habitual behavior and dopamine cell vulnerability in Parkinson disease.Proceedings: cell therapies for Parkinson's disease from discovery to clinic.Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neuronsDevelopment of a prediction formula of Parkinson disease severity by optical coherence tomography.The Multifaceted Roles of DJ-1 as an Antioxidant.Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.Commentary: Localized vs. Systematic Neurodegeneration: A Paradigm Shift in Understanding Neurodegenerative Diseases.Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review.Enteric nervous system manifestations of neurodegenerative disease.Neuroprotective Effects of Sulphated Agaran from Marine Alga Gracilaria cornea in Rat 6-Hydroxydopamine Parkinson's Disease Model: Behavioural, Neurochemical and Transcriptional Alterations.Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice.Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management.Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contacts
P2860
Q26778643-50452F62-CA96-47BE-80A3-AA272C9B74E5Q27301283-9BC2A777-E5EE-4519-B7C3-87D34FB2D323Q27694711-8A860D20-7BFE-4BC4-ADD4-D9E8FADE7469Q28391762-369BB3AB-ECB4-4CBA-A75D-F6B878A9D80CQ31060511-D464BA8D-2091-4881-8C52-D79DEF00C20AQ31080551-E8F7A847-2ADB-4320-ABAA-8C89FB3D13B1Q33613315-7564DD29-18CC-464C-836E-27AEC5E9F942Q33835242-00BECDA1-2A0B-414D-BE78-CE676F62D5D5Q35053448-6217F5AD-86EF-4A78-8EA2-52FF43F361E8Q35940803-D1084123-83DD-49CB-B83E-6098EB6F77CBQ36037330-7A4A9F03-5FC1-4DBD-85DA-3E73B2FC7629Q36042479-C972CBFB-1367-4994-9BF9-0AF8A2FB9F62Q36372732-248D7F5C-CA82-4654-AA7D-0C6F53B81EFAQ36373006-48DED6E4-2402-4A64-A3B4-3E0E3D013F22Q36661341-D099349D-4BC8-4B76-BF21-CA2F2F56EAE4Q38502393-1D4DAD9A-4B52-4639-8D71-CE41399230E3Q38626606-2E05CD22-08D9-470A-BBD2-BCB3C3147D60Q38777301-F3714FB7-C45D-4A70-98BA-2B17D6B42B35Q38790881-B0349133-8C6E-4F03-B412-67D1CED2EECAQ38939764-D285102B-8115-431A-A0BE-34B74D327FA7Q38969289-4A446DCB-9E96-4491-B1C0-40F9A8D521D3Q39095738-5BA24D9C-EBD3-40E4-9B7F-E6B24DD11EC7Q39631171-C934E7FC-4859-49FD-AB03-DE580F29B669Q41589030-B8E609F6-EB0B-4BD5-A645-9F8DF8D7331CQ42094999-42371159-011D-4786-BF6E-16D0CD526E42Q42177449-D8EFBB3B-0276-40BF-AB27-8A99391BB290Q42545361-8CE7A356-CB42-4E7D-9D4E-8E79EA736567Q42705179-E4188BF1-4B97-48DF-A0B7-42BE245851B6Q44875009-A9984E2F-411D-489E-BF5D-A589880E806BQ46259811-9E374E70-9395-4068-914B-3D7B14E96A87Q46970748-2F97E699-71FD-45F0-898E-1E48B7EA8042Q47153982-24B5B25B-B0E4-4C0A-9C4B-2B9F1904BB0CQ47183452-DE9183D5-B904-4D97-9375-C6899538D595Q47597895-F3D411B3-8DEF-4CFE-9097-0604F40937AFQ47845191-D329DFC7-E711-4B49-92C4-7E04D20CACCDQ48521515-74F3C742-2212-4AD6-97C2-2E65602A37A2Q50055334-4EBEB406-9BD5-4DD0-B88D-C8E2A6E91076Q52583507-301A128D-F8C3-4D88-9FD2-3C7556DE7F5DQ58716523-0F2CCD46-B0D5-4481-9E89-653C2EF7439E
P2860
Neuronal vulnerability, pathogenesis, and Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neuronal vulnerability, pathogenesis, and Parkinson's disease.
@en
type
label
Neuronal vulnerability, pathogenesis, and Parkinson's disease.
@en
prefLabel
Neuronal vulnerability, pathogenesis, and Parkinson's disease.
@en
P2860
P356
P1433
P1476
Neuronal vulnerability, pathogenesis, and Parkinson's disease.
@en
P2093
D James Surmeier
P2860
P304
P356
10.1002/MDS.25187
P407
P50
P577
2013-04-15T00:00:00Z